{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T03:35:41Z","timestamp":1794627341478,"version":"4.9.1"},"reference-count":85,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.semarthrit.2022.152060","type":"journal-article","created":{"date-parts":[[2022,7,3]],"date-time":"2022-07-03T09:39:41Z","timestamp":1656841181000},"page":"152060","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":112,"special_numbering":"C","title":["The economic burden of fibromyalgia: A systematic literature review"],"prefix":"10.1016","volume":"56","author":[{"given":"Martina","family":"D'Onghia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9446-7351","authenticated-orcid":false,"given":"Jacopo","family":"Ciaffi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piero","family":"Ruscitti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Cipriani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Giacomelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob N.","family":"Ablin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Ursini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.semarthrit.2022.152060_bib0001","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/s41584-020-00506-w","article-title":"Fibromyalgia: an update on clinical characteristics, aetiopathogenesis and treatment","volume":"16","author":"Sarzi-Puttini","year":"2020","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"10.1016\/j.semarthrit.2022.152060_bib0002","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2021-001735","article-title":"Fibromyalgia: a new facet of the post-COVID-19 syndrome spectrum? Results from a web-based survey","volume":"7","author":"Ursini","year":"2021","journal-title":"RMD Open"},{"issue":"2","key":"10.1016\/j.semarthrit.2022.152060_bib0003","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.semarthrit.2021.02.007","article-title":"Fibromyalgia and obesity: A comprehensive systematic review and meta-analysis","volume":"51","author":"D'Onghia","year":"2021","journal-title":"Semin Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.semarthrit.2022.152060_bib0004","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1002\/ejp.1252","article-title":"Comorbid fibromyalgia: A qualitative review of prevalence and importance","volume":"22","author":"Fitzcharles","year":"2018","journal-title":"Eur J Pain"},{"issue":"2","key":"10.1016\/j.semarthrit.2022.152060_bib0005","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/art.38905","article-title":"The prevalence of fibromyalgia in the general population: a comparison of the American College of Rheumatology 1990, 2010, and modified 2010 classification criteria","volume":"67","author":"Jones","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2022.152060_bib0006","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.pec.2008.06.005","article-title":"Patient perspectives on the impact of fibromyalgia","volume":"73","author":"Arnold","year":"2008","journal-title":"Patient Educ Couns"},{"issue":"7","key":"10.1016\/j.semarthrit.2022.152060_bib0007","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1097\/JOM.0b013e318222af81","article-title":"Musculoskeletal pain in the workforce: the effects of back, arthritis, and fibromyalgia pain on quality of life and work productivity","volume":"53","author":"McDonald","year":"2011","journal-title":"J Occup Environ Med"},{"key":"10.1016\/j.semarthrit.2022.152060_bib0008","doi-asserted-by":"crossref","first-page":"15022","DOI":"10.1038\/nrdp.2015.22","article-title":"Fibromyalgia","volume":"1","author":"H\u00e4user","year":"2015","journal-title":"Nat Rev Dis Primers"},{"issue":"4","key":"10.1016\/j.semarthrit.2022.152060_bib0009","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.semarthrit.2021.05.016","article-title":"Fibromyalgia syndrome - a risk factor for poor outcomes following orthopaedic surgery: A systematic review","volume":"51","author":"D'Onghia","year":"2021","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.semarthrit.2022.152060_bib0010","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1472-6963-10-102","article-title":"A patient survey of the impact of fibromyalgia and the journey to diagnosis","volume":"10","author":"Choy","year":"2010","journal-title":"BMC Health Services Research"},{"issue":"2","key":"10.1016\/j.semarthrit.2022.152060_bib0011","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0171186","article-title":"Determinants of quality of life in patients with fibromyalgia: A structural equation modeling approach","volume":"12","author":"Lee","year":"2017","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.semarthrit.2022.152060_bib0012","first-page":"867","article-title":"The economic impact of the rheumatic diseases in the United States","volume":"16","author":"Felts","year":"1989","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2022.152060_bib0013","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/00002281-200203000-00008","article-title":"Cost of illness studies in rheumatic diseases","volume":"14","author":"Fautrel","year":"2002","journal-title":"Curr Opin Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2022.152060_bib0014","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/art.21545","article-title":"The impact of a diagnosis of fibromyalgia on health care resource use by primary care patients in the UK: an observational study based on clinical practice","volume":"54","author":"Hughes","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"468","key":"10.1016\/j.semarthrit.2022.152060_bib0015","first-page":"553","article-title":"Frequency of attendance in general practice and symptoms before development of chronic fatigue syndrome: a case-control study","volume":"51","author":"Hamilton","year":"2001","journal-title":"Br J Gen Pract"},{"issue":"11","key":"10.1016\/j.semarthrit.2022.152060_bib0016","doi-asserted-by":"crossref","first-page":"e14729","DOI":"10.1111\/ijcp.14729","article-title":"Utilisation of healthcare services and drug consumption in fibromyalgia: A cross-sectional analysis of the Clalit Health Service database","volume":"75","author":"Gendelman","year":"2021","journal-title":"Int J Clin Pract"},{"issue":"1","key":"10.1016\/j.semarthrit.2022.152060_bib0017","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/wps.20692","article-title":"Economics and mental health: the current scenario","volume":"19","author":"Knapp","year":"2020","journal-title":"World Psychiatry"},{"issue":"9","key":"10.1016\/j.semarthrit.2022.152060_bib0018","doi-asserted-by":"crossref","first-page":"869","DOI":"10.2165\/00019053-200624090-00005","article-title":"Cost-of-illness studies : a review of current methods","volume":"24","author":"Akobundu","year":"2006","journal-title":"Pharmacoeconomics"},{"issue":"4","key":"10.1016\/j.semarthrit.2022.152060_bib0019","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3350\/cmh.2014.20.4.327","article-title":"Cost-of-illness studies: concepts, scopes, and methods","volume":"20","author":"Jo","year":"2014","journal-title":"Clin Mol Hepatol"},{"issue":"8","key":"10.1016\/j.semarthrit.2022.152060_bib0020","doi-asserted-by":"crossref","first-page":"653","DOI":"10.2165\/11588380-000000000-00000","article-title":"Cost-of-illness studies: a guide to critical evaluation","volume":"29","author":"Larg","year":"2011","journal-title":"Pharmacoeconomics"},{"issue":"3","key":"10.1016\/j.semarthrit.2022.152060_bib0021","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2307\/3349801","article-title":"Cost-of-illness methodology: a guide to current practices and procedures","volume":"60","author":"Hodgson","year":"1982","journal-title":"Milbank Mem Fund Q Health Soc"},{"issue":"1","key":"10.1016\/j.semarthrit.2022.152060_bib0022","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.healthpol.2005.07.016","article-title":"Cost-of-illness analysis. What room in health economics?","volume":"77","author":"Tarricone","year":"2006","journal-title":"Health Policy"},{"issue":"3","key":"10.1016\/j.semarthrit.2022.152060_bib0023","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2165\/00019053-200422030-00003","article-title":"A review of health-related workplace productivity loss instruments","volume":"22","author":"Lofland","year":"2004","journal-title":"Pharmacoeconomics"},{"issue":"10","key":"10.1016\/j.semarthrit.2022.152060_bib0024","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1097\/00043764-199910000-00007","article-title":"The role of health risk factors and disease on worker productivity","volume":"41","author":"Burton","year":"1999","journal-title":"J Occup Environ Med"},{"issue":"2","key":"10.1016\/j.semarthrit.2022.152060_bib0025","first-page":"91","volume":"2","author":"Shepard","year":"1999","journal-title":"Cost-effectiveness in Health and Medicine"},{"issue":"3","key":"10.1016\/j.semarthrit.2022.152060_bib0026","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s10198-016-0773-6","article-title":"Cost of diabetic eye, renal and foot complications: a methodological review","volume":"18","author":"Schirr-Bonnans","year":"2017","journal-title":"Eur J Health Econ"},{"issue":"5","key":"10.1016\/j.semarthrit.2022.152060_bib0027","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/j.1524-4733.2008.00327.x","article-title":"Methodological considerations in cost of prostate cancer studies: a systematic review","volume":"11","author":"Molinier","year":"2008","journal-title":"Value Health"},{"issue":"7 Suppl","key":"10.1016\/j.semarthrit.2022.152060_bib0028","first-page":"5","article-title":"Common methodological flaws in economic evaluations","volume":"43","author":"Drummond","year":"2005","journal-title":"Med Care"},{"issue":"1","key":"10.1016\/j.semarthrit.2022.152060_bib0029","doi-asserted-by":"crossref","DOI":"10.1080\/20008198.2020.1753940","article-title":"Economic evaluations and cost analyses in posttraumatic stress disorder: a systematic review","volume":"11","author":"von der Warth","year":"2020","journal-title":"Eur J Psychotraumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2022.152060_bib0030","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12992-017-0318-5","article-title":"Cost of diabetes mellitus in Africa: a systematic review of existing literature","volume":"14","author":"Mutyambizi","year":"2018","journal-title":"Global Health"},{"issue":"1","key":"10.1016\/j.semarthrit.2022.152060_bib0031","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s10741-017-9661-0","article-title":"Systematic review of economic burden of heart failure","volume":"23","author":"Shafie","year":"2018","journal-title":"Heart Fail Rev"},{"issue":"1","key":"10.1016\/j.semarthrit.2022.152060_bib0032","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s40258-017-0346-6","article-title":"A Systematic Review of Cost-of-Illness Studies of Multimorbidity","volume":"16","author":"Wang","year":"2018","journal-title":"Appl Health Econ Health Policy"},{"issue":"24","key":"10.1016\/j.semarthrit.2022.152060_bib0033","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1016\/j.vaccine.2017.04.050","article-title":"Cost-effectiveness analysis of vaccinations and decision makings on vaccination programmes in Hong Kong: A systematic review","volume":"35","author":"Wong","year":"2017","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.semarthrit.2022.152060_bib0034","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1136\/oemed-2012-100668","article-title":"Worksite mental health interventions: a systematic review of economic evaluations","volume":"69","author":"Hamberg-van Reenen","year":"2012","journal-title":"Occup Environ Med"},{"issue":"1","key":"10.1016\/j.semarthrit.2022.152060_bib0035","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s40273-019-00849-7","article-title":"Economic Burden of Anxiety Disorders: A Systematic Review and Meta-Analysis","volume":"38","author":"Konnopka","year":"2020","journal-title":"Pharmacoeconomics"},{"issue":"1","key":"10.1016\/j.semarthrit.2022.152060_bib0036","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12872-018-0815-3","article-title":"Cost-of-illness studies in heart failure: a systematic review 2004-2016","volume":"18","author":"Lesyuk","year":"2018","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.semarthrit.2022.152060_bib0037","doi-asserted-by":"crossref","first-page":"e161","DOI":"10.1017\/S204579602000075X","article-title":"The cost of mental disorders: a systematic review","volume":"29","author":"Christensen","year":"2020","journal-title":"Epidemiol Psychiatr Sci"},{"key":"10.1016\/j.semarthrit.2022.152060_bib0038","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1017\/S2045796019000180","article-title":"The excess costs of depression: a systematic review and meta-analysis","volume":"29","author":"K\u00f6nig","year":"2019","journal-title":"Epidemiol Psychiatr Sci"},{"issue":"sup4","key":"10.1016\/j.semarthrit.2022.152060_bib0039","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.12968\/jowc.2017.26.Sup4.S4","article-title":"Cost-of-illness studies in chronic ulcers: a systematic review","volume":"26","author":"Chan","year":"2017","journal-title":"J Wound Care"},{"issue":"4","key":"10.1016\/j.semarthrit.2022.152060_bib0040","first-page":"885","article-title":"The London Fibromyalgia Epidemiology Study: direct health care costs of fibromyalgia syndrome in London, Canada","volume":"26","author":"White","year":"1999","journal-title":"J Rheumatol"},{"issue":"9","key":"10.1016\/j.semarthrit.2022.152060_bib0041","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1111\/j.1742-1241.2007.01480.x","article-title":"Characteristics and healthcare costs of patients with fibromyalgia syndrome","volume":"61","author":"Berger","year":"2007","journal-title":"Int J Clin Pract"},{"issue":"5 Suppl","key":"10.1016\/j.semarthrit.2022.152060_bib0042","first-page":"S126","article-title":"Patterns of healthcare utilization and cost in patients with newly diagnosed fibromyalgia","volume":"16","author":"Berger","year":"2010","journal-title":"Am J Manag Care"},{"issue":"9","key":"10.1016\/j.semarthrit.2022.152060_bib0043","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.7205\/MILMED-D-13-00419","article-title":"Prevalence, health care utilization, and costs of fibromyalgia, irritable bowel, and chronic fatigue syndromes in the military health system, 2006-2010","volume":"179","author":"Jeffery","year":"2014","journal-title":"Mil Med"},{"issue":"4","key":"10.1016\/j.semarthrit.2022.152060_bib0044","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/pme.12328","article-title":"Characteristics, treatment, and health care expenditures of Medicare supplemental-insured patients with painful diabetic peripheral neuropathy, post-herpetic neuralgia, or fibromyalgia","volume":"15","author":"Johnston","year":"2014","journal-title":"Pain Med"},{"key":"10.1016\/j.semarthrit.2022.152060_bib0045","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2147\/CEOR.S41111","article-title":"Health-resource use and costs associated with fibromyalgia in France, Germany, and the United States","volume":"5","author":"Knight","year":"2013","journal-title":"Clinicoecon Outcomes Res"},{"issue":"12","key":"10.1016\/j.semarthrit.2022.152060_bib0046","first-page":"2711","article-title":"Effects of social support and education on health care costs for patients with fibromyalgia","volume":"28","author":"Oliver","year":"2001","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.semarthrit.2022.152060_bib0047","article-title":"Healthcare Costs Associated With Chronic Opioid Use and Fibromayalgia Syndrome","volume":"6","author":"Painter","year":"2014","journal-title":"Am J Pharm Benefits"},{"issue":"8","key":"10.1016\/j.semarthrit.2022.152060_bib0048","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1111\/papr.12357","article-title":"Cost Burden of Chronic Pain Patients in a Large Integrated Delivery System in the United States","volume":"16","author":"Park","year":"2016","journal-title":"Pain Pract"},{"issue":"6","key":"10.1016\/j.semarthrit.2022.152060_bib0049","first-page":"1318","article-title":"Economic cost and epidemiological characteristics of patients with fibromyalgia claims","volume":"30","author":"Robinson","year":"2003","journal-title":"J Rheumatol"},{"issue":"8","key":"10.1016\/j.semarthrit.2022.152060_bib0050","first-page":"1621","article-title":"Depression and fibromyalgia: treatment and cost when diagnosed separately or concurrently","volume":"31","author":"Robinson","year":"2004","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.semarthrit.2022.152060_bib0051","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1185\/03007995.2010.550605","article-title":"Longitudinal evaluation of health care utilization and costs during the first three years after a new diagnosis of fibromyalgia","volume":"27","author":"Sanchez","year":"2011","journal-title":"Curr Med Res Opin"},{"issue":"11","key":"10.1016\/j.semarthrit.2022.152060_bib0052","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1007\/s10067-012-2051-z","article-title":"Fibromyalgia and hysterectomy: the impact on health status and health care costs","volume":"31","author":"Santoro","year":"2012","journal-title":"Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2022.152060_bib0053","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3109\/10582452.2013.795639","article-title":"Depression, Self-Efficacy, Health Status, and Health Care Costs: A Comparison of Men with Fibromyalgia or Osteoarthritis","volume":"21","author":"Santoro","year":"2013","journal-title":"Journal of Musculoskeletal Pain"},{"issue":"5","key":"10.1016\/j.semarthrit.2022.152060_bib0054","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/papr.12302","article-title":"The Comparative Burden of Chronic Widespread Pain and Fibromyalgia in the United States","volume":"16","author":"Schaefer","year":"2016","journal-title":"Pain Pract"},{"issue":"4","key":"10.1016\/j.semarthrit.2022.152060_bib0055","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1185\/03007990902728456","article-title":"The economic burden of fibromyalgia: comparative analysis with rheumatoid arthritis","volume":"25","author":"Silverman","year":"2009","journal-title":"Curr Med Res Opin"},{"issue":"1","key":"10.1016\/j.semarthrit.2022.152060_bib0056","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/PHM.0b013e3181fc7ff3","article-title":"Direct medical costs in patients with fibromyalgia: Cost of illness and impact of a brief multidisciplinary treatment program","volume":"90","author":"Thompson","year":"2011","journal-title":"Am J Phys Med Rehabil"},{"issue":"1","key":"10.1016\/j.semarthrit.2022.152060_bib0057","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/JOM.0b013e31815cff4b","article-title":"Employees with fibromyalgia: medical comorbidity, healthcare costs, and work loss","volume":"50","author":"White","year":"2008","journal-title":"J Occup Environ Med"},{"issue":"9","key":"10.1016\/j.semarthrit.2022.152060_bib0058","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.jpain.2009.03.012","article-title":"Comparison of health care use and costs in newly diagnosed and established patients with fibromyalgia","volume":"10","author":"White","year":"2009","journal-title":"J Pain"},{"issue":"9","key":"10.1016\/j.semarthrit.2022.152060_bib0059","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/art.1780400904","article-title":"A prospective, longitudinal, multicenter study of service utilization and costs in fibromyalgia","volume":"40","author":"Wolfe","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2022.152060_bib0060","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s12891-016-1027-6","article-title":"Fibromyalgia-related costs and loss of productivity: a substantial societal burden","volume":"17","author":"Lacasse","year":"2016","journal-title":"BMC Musculoskelet Disord"},{"issue":"4","key":"10.1016\/j.semarthrit.2022.152060_bib0061","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/AJP.0b013e3181cf599f","article-title":"Clinical and economic characteristics of patients with fibromyalgia syndrome","volume":"26","author":"Lachaine","year":"2010","journal-title":"Clin J Pain"},{"issue":"7","key":"10.1016\/j.semarthrit.2022.152060_bib0062","first-page":"1391","article-title":"Health services costs and their determinants in women with fibromyalgia","volume":"31","author":"Penrod","year":"2004","journal-title":"J Rheumatol"},{"issue":"6 Suppl 63","key":"10.1016\/j.semarthrit.2022.152060_bib0063","first-page":"S64","article-title":"Health economic evaluation of outpatient management of fibromyalgia patients and the costs avoided by diagnosing fibromyalgia in France","volume":"28","author":"Lamotte","year":"2010","journal-title":"Clin Exp Rheumatol"},{"issue":"8","key":"10.1016\/j.semarthrit.2022.152060_bib0064","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1097\/AJP.0b013e318270f99a","article-title":"Cost-utility of a psychoeducational intervention in fibromyalgia patients compared with usual care: an economic evaluation alongside a 12-month randomized controlled trial","volume":"29","author":"Luciano","year":"2013","journal-title":"Clin J Pain"},{"issue":"5 Suppl 56","key":"10.1016\/j.semarthrit.2022.152060_bib0065","first-page":"S39","article-title":"Resource utilisation and health care costs in patients diagnosed with fibromyalgia in Spain","volume":"27","author":"Rivera","year":"2009","journal-title":"Clin Exp Rheumatol"},{"issue":"6 Suppl 74","key":"10.1016\/j.semarthrit.2022.152060_bib0066","first-page":"31","article-title":"Prospective study of the use of healthcare resources and economic costs in patients with fibromyalgia after treatment in routine medical practice","volume":"30","author":"Rivera","year":"2012","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2022.152060_bib0067","doi-asserted-by":"crossref","first-page":"R54","DOI":"10.1186\/ar2673","article-title":"Treating patients with fibromyalgia in primary care settings under routine medical practice: a claim database cost and burden of illness study","volume":"11","author":"Sicras-Mainar","year":"2009","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"10.1016\/j.semarthrit.2022.152060_bib0068","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2165\/11535250-000000000-00000","article-title":"Impact of fibromyalgia severity on health economic costs: results from a European cross-sectional study","volume":"9","author":"Winkelmann","year":"2011","journal-title":"Appl Health Econ Health Policy"},{"key":"10.1016\/j.semarthrit.2022.152060_bib0069","first-page":"113","article-title":"A burden of illness study for neuropathic pain in Europe","volume":"8","author":"Liedgens","year":"2016","journal-title":"Clinicoecon Outcomes Res"},{"issue":"3","key":"10.1016\/j.semarthrit.2022.152060_bib0070","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1136\/ard.2003.019711","article-title":"Large differences in cost of illness and wellbeing between patients with fibromyalgia, chronic low back pain, or ankylosing spondylitis","volume":"64","author":"Boonen","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.semarthrit.2022.152060_bib0071","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s10067-012-2100-7","article-title":"Challenges in demonstrating the effectiveness of multidisciplinary treatment on quality of life, participation and health care utilisation in patients with fibromyalgia: a randomised controlled trial","volume":"32","author":"van Eijk-Hustings","year":"2013","journal-title":"Clin Rheumatol"},{"issue":"2 Suppl 96","key":"10.1016\/j.semarthrit.2022.152060_bib0072","first-page":"S74","article-title":"Cost of illness and illness perceptions in patients with fibromyalgia","volume":"34","author":"Vervoort","year":"2016","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"10.1016\/j.semarthrit.2022.152060_bib0073","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/fampra\/cmh411","article-title":"The clinical and economic burden of fibromyalgia compared with diabetes mellitus and hypertension among Bedouin women in the Negev","volume":"21","author":"Doron","year":"2004","journal-title":"Fam Pract"},{"issue":"5","key":"10.1016\/j.semarthrit.2022.152060_bib0074","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/1756-185X.14094","article-title":"High cost of illness in fibromyalgia patients in Iran, irrespective of disease severity: A prospective cost study","volume":"24","author":"Gharibpoor","year":"2021","journal-title":"Int J Rheum Dis"},{"issue":"2","key":"10.1016\/j.semarthrit.2022.152060_bib0075","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1093\/rheumatology\/kes255","article-title":"Effect of fibromyalgia syndrome on the health-related quality of life and economic burden in Korea","volume":"52","author":"Kim","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2022.152060_bib0076","doi-asserted-by":"crossref","first-page":"967","DOI":"10.2147\/JPR.S110707","article-title":"Humanistic and economic burden of fibromyalgia in Japan","volume":"9","author":"Lee","year":"2016","journal-title":"J Pain Res"},{"key":"10.1016\/j.semarthrit.2022.152060_bib0077","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1472-6963-10-102","article-title":"A patient survey of the impact of fibromyalgia and the journey to diagnosis","volume":"10","author":"Choy","year":"2010","journal-title":"BMC Health Serv Res"},{"issue":"2","key":"10.1016\/j.semarthrit.2022.152060_bib0078","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1136\/annrheumdis-2016-209724","article-title":"EULAR revised recommendations for the management of fibromyalgia","volume":"76","author":"Macfarlane","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.semarthrit.2022.152060_bib0079","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.3899\/jrheum.170098","article-title":"Adherence and Persistence with Drug Therapy among Fibromyalgia Patients: Data from a Large Health Maintenance Organization","volume":"44","author":"Ben-Ami Shor","year":"2017","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.semarthrit.2022.152060_bib0080","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s40273-014-0137-y","article-title":"Fibromyalgia: disease synopsis, medication cost effectiveness and economic burden","volume":"32","author":"Skaer","year":"2014","journal-title":"Pharmacoeconomics"},{"issue":"3","key":"10.1016\/j.semarthrit.2022.152060_bib0081","doi-asserted-by":"crossref","first-page":"232","DOI":"10.4212\/cjhp.v68i3.1457","article-title":"An Introduction to Health Care Administrative Data","volume":"68","author":"Cadarette","year":"2015","journal-title":"Can J Hosp Pharm"},{"issue":"2","key":"10.1016\/j.semarthrit.2022.152060_bib0082","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.diabres.2014.03.020","article-title":"Cost-of-illness studies of diabetes mellitus: a systematic review","volume":"105","author":"Ng","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"issue":"7245","key":"10.1016\/j.semarthrit.2022.152060_bib0083","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1136\/bmj.320.7245.1335","article-title":"Economic note: cost of illness studies","volume":"320","author":"Byford","year":"2000","journal-title":"Bmj"},{"issue":"2","key":"10.1016\/j.semarthrit.2022.152060_bib0084","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2165\/00019053-200119020-00007","article-title":"Usefulness of US cost-of-illness studies in healthcare decision making","volume":"19","author":"Bloom","year":"2001","journal-title":"Pharmacoeconomics"},{"issue":"1","key":"10.1016\/j.semarthrit.2022.152060_bib0085","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.spinee.2007.10.005","article-title":"A systematic review of low back pain cost of illness studies in the United States and internationally","volume":"8","author":"Dagenais","year":"2008","journal-title":"Spine J"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017222001111?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017222001111?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:10:30Z","timestamp":1758733830000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017222001111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":85,"alternative-id":["S0049017222001111"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2022.152060","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The economic burden of fibromyalgia: A systematic literature review","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2022.152060","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"152060"}}